UNeMed Reports 39 New Patents in Annual Innovation Data
The report underscores the output of Omaha's university-led commercialization efforts for the 2026 fiscal year.
Updated on Oct. 16, 2026 in Biotech
Live Poll
Does your local community do enough to turn academic research into new local businesses?
UNeMed highlighted institutional growth at its 2026 Innovation Awards ceremony, recognizing advancements in fields ranging from injectable therapy software to respiratory protection. The organization reported 136 new invention submissions and 39 issued patents for the fiscal year ending in 2026.
Why it matters
This data underscores the current patent and invention output emerging from the University of Nebraska medical and research ecosystems. The awards highlight the institutional pipeline for academic commercialization and startup formation in Omaha.
UNeMed secured 39 total patents during the 2026 fiscal year, comprising 19 U.S. patents and 20 foreign filings. These figures reflect the current intellectual property output from 235 active researchers across the university system.
The players
UNeMed
The technology transfer office for the University of Nebraska Medical Center that manages patent filings and commercialization.
Goldenrod Therapeutics
A startup recognized as the 2026 Startup of the Year within the university's innovation ecosystem.
Josh Havens
An inventor awarded for software development focused on managing injectable therapies.
Joel Elson
An inventor recognized for his work on anti-terrorism chatbot technology.
Elizabeth Beam
A faculty member honored for developing a respiratory protection device.
The details
The university commercialization pipeline functions through an internal selection process managed by UNeMed and UNeTech. This process evaluates novel intellectual property—creations or discoveries eligible for legal protection—from faculty and students for market viability. Selected projects are then supported through professionalized patent filing and commercialization pathways, such as the newly recognized respiratory protection device and injectable therapy management software.
Timeline
Oct. 12-16, 2026: Innovation Week programming.
Oct. 14, 2026: The 2026 Innovation Awards ceremony took place at the Scott Conference Center.
2027: The Steel Works Health Accelerator is scheduled to continue operations.
The Tech Race
The regional push for commercialization aligns with the ongoing operations of the Steel Works Health Accelerator, which announced its second cohort in August 2026. This activity places Omaha in direct competition with emerging biotech clusters that leverage dedicated university-led incubation models.
Researchers and local entrepreneurs should monitor UNeMed programming for potential participation in future cohorts like the Steel Works Health Accelerator. The organization's ongoing patent support remains the primary pathway for faculty seeking to move research from the lab to commercial application.
The takeaway
UNeMed continues to prioritize patent diversification with nearly half of its 2026 portfolio originating from foreign jurisdictions. Observers should track the 2027 performance of startups like Goldenrod Therapeutics as a metric for the success of these university-backed ventures.
Further reading
Explore more developments in the local ecosystem on the Biotech page.
Source note: This article includes information reported by Silicon Prairie News.
Live Poll
Does your local community do enough to turn academic research into new local businesses?
